![]() |
|
|
Vol. 29, Issue 10, 1349-1354, October 2001
Laboratory of Pneumology, Unit of Lung Toxicology, Katholieke Universiteit Leuven, Leuven, Belgium (S.D., P.H.M.H., B.N.); and Institute of Physiology, Bulgarian Academy of Sciences, Sofia, Bulgaria (S.D.)
| |
Abstract |
|---|
|
|
|---|
Because of the evidence for the involvement of xenobiotic
bioactivation in pulmonary toxicity and carcinogenesis, it is important to improve our understanding of the xenobiotic-metabolizing enzymes in
isolated and cultured specific pulmonary cell populations. Some phase I
and phase II xenobiotic-metabolizing enzyme activities, reduced
glutathione (GSH), and
-glutamyl transferase (
-GT) were studied
in rat type II pneumocytes and alveolar macrophages cultured for up to
48 h and 3 h, respectively. In type II pneumocytes, 7-ethoxyresorufin activity was not detected. 7-Benzyloxyresorufin (BROD) and 7-pentoxyresorufin (PROD) O-dealkylation
decreased at 24 h by 84 and 82%, respectively, and continued to
decline over the next 24 h with no measurable PROD at 48 h.
The activity of NADPH- and NADH-cytochrome c reductase
at 48 h decreased by 31 and 67%, respectively. GST activity
decreased by 25 and 42% at 24 and 48 h, respectively. A transient
increase in DT-diaphorase activity was observed at 24 h (by 55%).
GSH content and
-GT activity increased significantly with time in
culture. In freshly isolated alveolar macrophages, BROD activity was
the only cytochrome P450-dependent alkoxyresorufin-O-dealkylase activity measured. BROD
activity decreased by 38% in 3-h-attached macrophages. There were no
changes in NADPH- and NADH-cytochrome c reductase, GST,
and DT-diaphorase. An increase of GSH (by 24%) was observed in
attached macrophages. In conclusion, type II pneumocytes and to a
lesser extent alveolar macrophages in primary cultures undergo changes
in biotransformation-related enzyme activities and intracellular GSH
level that may affect xenobiotic toxicity at different times in culture.
| |
Introduction |
|---|
|
|
|---|
The
lung represents one of the major targets for exposure to xenobiotics
not only because it is the primary site for the entrance of airborne
agents but also because it receives 100% of the cardiac output. As one
of the extrahepatic organs involved in the biotransformation, the lung
contains several enzymatic pathways capable of xenobiotic metabolism
(Devereux et al., 1993
). These include the cytochrome P450
(CYP1) superfamily of enzymes, which is the main
system catalyzing the oxidative metabolism and metabolic activation of
toxic compounds and procarcinogens, as well as phase II enzymes such as
glutathione S-transferase, DT-diaphorase, and
UDP-glucuronyltransferase, which also play a role in the early cellular
defense against toxicity and tumorogenesis (Bogdanffy and Keller,
1999
). The susceptibility of the lung to xenobiotics depends on the
metabolic balance between toxication and detoxication pathways (Hayashi
et al., 1992
).
In the lung, CYP is localized in Clara cells, alveolar type II and type
I cells, endothelial cells, macrophages, and ciliated bronchiolar cells
(Devereux et al., 1993
; Lee and Dinsdale, 1995
). The nonuniform
distribution of xenobiotic bioactivation and detoxication enzymes has
been suggested as a basis for cell-specific toxicity observed with many
lung-damaging chemicals (Minchin and Boyd, 1983
). The use of isolated
pulmonary cells constitutes a valuable system for studying mechanisms
involved in xenobiotic-induced toxicity (Nemery and Hoet, 1993
;
Schwarze et al., 1996
) and seems to be a good model system to examine
the cellular regulation of the CYP monooxygenase pathways in the lung
(Devereux et al., 1993
; Låg et al., 1996
).
Rodent type II pneumocytes and alveolar macrophages have been
extensively used for in vitro toxicological studies. The type II
epithelial cells play a critical role in toxicant-induced damage, can
metabolize many xenobiotic compounds, and represent possible targets in
lung carcinogenesis (Schwarze et al., 1996
). Alveolar macrophages play
an important role in lung defense and in inflammatory responses.
Activated alveolar macrophages and their secretory products may also
contribute to a variety of lung disorders induced by xenobiotics
(Laskin and Laskin, 2001
).
Type II pneumocytes are known to alter their phenotype within the first
days in culture and to change toward characteristics that are more type
I cell-like (Dobbs, 1990
). However, most of the studies have focused on
morphological changes, production of surfactant phospholipids and
apoproteins, and antioxidant enzyme activities (Kalina and Riklis,
1988
; Dobbs, 1990
; Kinnula et al., 1992
). Although
xenobiotic-metabolizing enzymes have been extensively characterized in
freshly isolated type II pneumocytes and alveolar macrophages (Domin et
al., 1986
; Devereux et al., 1993
), little is known concerning the
effect of time in culture on the maintenance of these enzymes. Several
studies carried out on hepatocytes have shown the rapid loss of CYP and
phase II-catalyzing enzymes after cell isolation and plating (Rogiers
and Vercruysse, 1993
; Kern et al., 1997
). In cultures of rat type II
pneumocytes and Clara cells, Låg et al. (1996)
have found a decrease
in CYP2B1 apoenzyme expression with time in culture.
The aim of the present study was to improve our knowledge of the activity of some xenobiotic-metabolizing enzymes of rat type II pneumocytes and alveolar macrophages in primary cultures.
Experimental Procedures
Chemicals and Materials.
Trypsin type I (EC 3.4.214, catalog no. T-8003), reduced glutathione
(GSH), NADH, NADPH, metaphosphoric acid, bovine serum albumin,
Percoll, EDTA, o-phthaldialdehyde,
3,3'-methylene-bis(4-hydroxycoumarin) (dicumarol), cytochrome
c, 1 chloro-2,4-dinitrobenzene,
2,6-dichlorophenol-indophenol, 7-ethoxyresorufin, 7-pentoxyresorufin,
7-benzyloxyresorufin, and a
-glutamyl transferase diagnostic kit
were purchased from Sigma-Aldrich NV/SA (Bornem, Belgium). Dulbecco's
modified Eagle's medium (DMEM), fetal bovine serum (FBS),
penicillin-streptomycin solution (10,000 U/ml and 10,000 µg/ml,
respectively), amphotericin B (250 µg/ml), and
L-glutamine (200 mM) were obtained from
Invitrogen (Merelbeke, Belgium). Deoxyribonuclease (DNase) I (EC
3.1.21.1) was purchased from Roche Molecular Biochemicals
(Mannheim, Germany). Protein assay dye solution was obtained from
Bio-Rad (Brussels, Belgium). All other chemicals were purchased from
U.C.B. (Brussels, Belgium). Tissue culture plates (24- and 6-well
plates) were purchased from Iwaki Glass (International Medical,
Brussels, Belgium).
Animals. Male Wistar rats with a mean weight of 191 g (range, 174-215 g) were used. The animals were obtained from an in-house strain and were maintained in a conventional animal house with 12-h dark/light cycles in metal cages with a wired bottom. Animals were allowed free access to standard laboratory diet and tap water.
Cell Isolation and Plating.
A population of enriched type II pneumocytes was isolated from rat
lung, according to the method of Hoet et al. (1995)
, which includes
lung perfusion, trypsin digestion, Percoll gradient centrifugation, and
differential adherence. Briefly, the rats were anesthetized with
pentobarbital (90-mg/kg i.p.) and euthanized by exsanguination. The
trachea was cannulated, and the lungs were perfused with 0.9% NaCl via
the pulmonary artery and ventilated 5 times with 5 to 8 ml of air. The
lungs were excised and lavaged via the trachea with 0.9% NaCl (5 times
with 3.5 ml/100 g of body weight). The lungs were trypsinized (250 mg
of trypsin in 100 ml of phosphate-buffered saline with calcium and
magnesium; PBS+, 130 mM NaCl, 5.2 mM KCl, 10 mM
glucose, 10.6 mM Hepes, 2.6 mM Na2HPO4, 1.9 mM
CaCl2, 1.29 mM MgSO4, pH
7.4, per rat lung) during 30 min at 37°C. The lungs were chopped, and
5 ml of FBS and 3 mg of DNase I were added. After shaking and
filtering, the cell suspension was layered onto a discontinuous Percoll
gradient (density, 1.089 and 1.040 g/ml) and centrifuged at
250g for 20 min (10°C). The cells of the creamy layer
above the heavy gradient were plated in a 60-mm diameter culture dish
and incubated for 1 h (5% CO2, 37°C) to
let the macrophages attach. The unattached cells were suspended in DMEM
supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml
streptomycin, 1.25 µg/ml Fungizone, and 2 mM glutamine. An average of
5.5 × 106 cells were isolated per animal
(range, 4-8 × 106), and the cell
viability, as assessed by trypan blue exclusion, was 98% (range,
96-99). Identification of type II pneumocytes was carried out with the
alkaline phosphatase stain. The proportions of alkaline
phosphatase-stained cells in freshly isolated cell preparations and
after 24 and 48 h in culture were 74 ± 8 (n = 6), 83 ± 1 (n = 4), and 96 ± 2%
(n = 4), respectively.
Enzyme Assays.
For the determination of enzyme activities, the cells were scraped on
ice with a rubber policeman in buffer containing 10 mM Tris, 150 mM
KCl, and 1 mM EDTA, pH 7.4. Aliquots of the freshly isolated cells were
suspended in the same buffer. All samples were immediately frozen at
80°C. Before the assays, the cell samples were homogenized by
sonication on ice with a probe sonicator (Instruments Scientifiques
Analis, Namur, Belgium) at an amplitude of 18 µm peak-to-peak for
15 s. A 50-µl aliquot was taken for protein determination. The
O-dealkylation of 7-ethoxyresorufin (EROD), PROD, and BROD
were determined by the method of Lubet et al. (1985)
. The initial
linear rate (5 min) of resorufin formation was measured
spectrofluorometrically (excitation, 550 nm; emission, 586 nm) at
37°C using a Shimadzu RF-5001PC fluorescence spectrophotometer (Shimadzu, Benelux, Antwerpen, Belgium). The reaction mixture (1 ml)
consisted of 50 mM Tris, 25 mM MgCl2 buffer, pH
7.5, 100 µM NADPH, substrate (1 µM 7-ethoxyresorufin, 5 µM
7-pentoxyresorufin, or 5 µM 7-benzyloxyresorufin), and sonicated cell
suspension (200-500 µg of protein). Dicumarol (20 µM final
concentration) was added to the assay medium to prevent the
biotransformation of resorufin by cytosolic diaphorase. At the end of
the incubation, 10 pmol of resorufin was added as an internal standard.
The results were expressed as picomoles of resorufin formed per minute
per milligram of cell protein.
1 cm
1.
Glutathione S-transferase (GST) activity was determined
spectrophotometrically at 25°C, with 1-chloro-2,4-dinitrobenzene as a
general substrate (Habig et al., 1974
1 cm
1 was used to
express the results as nanomoles per minute per milligram of protein.
The activity of cytosolic DT-diaphorase was determined according to the
method of Fisher and Gutierrez (1991)
1
cm
1 was used to express the results in
nanomoles of reduced substrate per milligram of protein per minute.
Gamma-glutamyl transferase (
-GT) activity was measured in sonicated
cell suspensions (20-40 µg of protein in 100 µl) using
-glutamyltransferase reagent (500 µl) obtained from Sigma-Aldrich S.A. (Bornem, Belgium). The rate of formation of
5-amino-2-nitrobenzoate was recorded at 405 nm at 37°C for 2 min. The
results were expressed as milliunits per milligram of cell protein,
using an extinction coefficient of 9.5 mM
1
cm
1.
GSH Determination.
The cells were deproteinized in 200 µl of metaphosphoric acid (5% in
0.1 M phosphate, 0.005 M EDTA buffer, pH 8.0), samples were centrifuged
at 14,000g for 15 min, and the supernatant was analyzed by
the fluorometric method of Hissin and Hilf (1976)
as previously
described (Dimova et al., 2000
). A standard curve using GSH was
prepared for each run. GSH content was expressed as nanomoles per
milligram of cell protein.
Protein Determination.
The sonicated cell suspensions and precipitated proteins were dissolved
in 1 N NaOH. The cell protein content was determined using the method
of Bradford (1976)
after neutralization with 0.333 N HCl. Bovine serum
albumin was used as the standard.
Statistical Analysis. The results are presented as means ± S.D. of three to six independent experiments. The data were statistically analyzed by repeated measures ANOVA followed by Bonferroni's multiple comparison test or by Student's t test (GraphPad Prism package; GraphPad Software, San Diego, CA). The minimum level of significance was considered to be p < 0.05. Statistical analysis was performed before the data were transformed to percentages.
| |
Results |
|---|
|
|
|---|
Xenobiotic-metabolizing enzyme activities, intracellular GSH, and
-GT activity were studied in freshly isolated rat type II
pneumocytes (initial values, 0 h) and after 24 and 48 h in culture and in freshly isolated and 3-h-attached rat alveolar macrophages. The absolute values of the parameters studied in freshly
isolated type II pneumocytes and alveolar macrophages are shown in
Table 1. Freshly isolated type II
pneumocytes possessed higher BROD, NADPH- and NADH-cytochrome
c reductases, DT-diaphorase, and GST activities compared
with freshly isolated alveolar macrophages. No difference was observed
in intracellular GSH content, calculated per milligram of cell protein.
At the protein concentrations used, EROD activity was undetectable in
both type II pneumocytes and alveolar macrophages. In macrophages, PROD
and
-GT activities were also below the detection limits.
|
The CYP-dependent alkoxyresorufin-O-dealkylation in type II pneumocytes was considerably lost with time in culture (Fig. 1A). At 24 h, the BROD and PROD activities decreased by 84 and 82%, respectively, and they continued to decline over the next 24 h, with no measurable PROD activity at 48 h. The activity of NADPH-cytochrome c reductase, considered to be mainly due to the presence of CYP reductase, was relatively stable at 24 h but decreased by 31% at 48 h compared with freshly isolated type II pneumocytes (Fig. 1B). NADH-cytochrome c reductase activity decreased with time in culture by 42 and 51% at 24 and 48 h, respectively.
|
In contrast to CYP-related activities, the activity of cytosolic
DT-diaphorase was increased at 24 h (by 50%) and then decreased to approximately the initial level at 48 h (Fig. 1D). The activity of GST decreased continuously as a function of time (Fig. 1C), but more
slowly than did BROD and PROD activities. After 24 h and 48 h
in culture, GST activity in type II pneumocytes significantly decreased
by 25 and 42%, respectively. At the same time, the intracellular GSH
content increased, and at 48 h, it was elevated by 159% compared with freshly isolated type II pneumocytes (Fig.
2A). The increase in intracellular GSH
level was associated with an increase in
-GT activity by 45 and 95%
at 24 and 48 h, respectively (Fig. 2B).
|
In 3-h-attached alveolar macrophages, the BROD activity decreased by 38% compared with freshly isolated cells (Fig. 3A). There were no changes in NADPH- and NADH-cytochrome c reductase, GST, and DT-diaphorase activities in 3-h-attached alveolar macrophages (Fig. 3, A and B). An increase of intracellular GSH (by 24%) was observed in the cultured macrophages.
|
| |
Discussion |
|---|
|
|
|---|
The present study demonstrates that rat type II pneumocyte
cultures undergo a decrease in the activities of BROD, PROD, NADPH- and
NADH-cytochrome c-reductase, and GST and an increase of
DT-diaphorase, intracellular GSH, and
-GT. In alveolar macrophages,
a decrease in BROD activity and increase in GSH occur after 3 h in
culture. The time points (0, 24, and 48 h in type II pneumocytes;
0 and 3 h in alveolar macrophages) were chosen because of their
common use in studying xenobiotic toxicity in these cells.
We determined the activities, rather than apoprotein or mRNA levels of
the xenobiotic-metabolizing enzymes, because activities represent a
true measure of the corresponding enzyme performance. The activities
found in freshly isolated rat type II pneumocytes and alveolar
macrophages were in the range of those previously reported (Lacy et
al., 1992
; Devereux et al., 1993
). The most important CYP isoenzymes
identified in rat lung are CYP2B1, 3A, 4B, 2F, 1A1, and 2E1 (Bogdanffy
and Keller, 1999
). Benzyloxyresorufin is a substrate for several
isoenzymes, including CYP1A1, 2B1 and 3A1 (Wolf et al., 1986
).
Pentoxyresorufin shows high specificity for CYP2B1, and it was
established that it is also a substrate for CYP2F1 (Nhamburo et al.,
1990
). Because CYP2B1 is the main constitutive CYP present in rat lung
(Guengerich, 1990
), we suggest that the greatest part of PROD and BROD
is related to CYP2B1, but CYP2F1 and 3A1 can also contribute to these
activities. We found 37 times lower BROD activity and undetectable PROD
activity in alveolar macrophages compared with type II pneumocytes,
which is in agreement with the levels of expression of CYP2B1 mRNA in these cells, as reported by Låg et al. (1996)
. CYP1A1-associated EROD
activity was undetectable in freshly isolated type II pneumocytes and
alveolar macrophages. This may be due to a combination of low activity
and limitation of the detection assay. In uninduced rat lung, CYP1A1 is
generally present at very low levels (Marcus et al., 1990
). EROD
activity has been measured in microsomes isolated from Clara and type
II cells (Domin et al., 1986
) and macrophages (Germolec et al., 1995
)
but not in sonicated cell suspensions of rat type II pneumocytes and
alveolar macrophages (Lacy et al., 1992
).
Freshly isolated type II pneumocytes exhibited 6-fold greater
DT-diaphorase activity than alveolar macrophages. This is in line with
the results of Siegel et al. (1988)
, who found a minimal DT-diaphorase
activity in mouse alveolar macrophages and showed that type II
pneumocytes are the site of DT-diaphorase activity in rodent
lung. In rat lung, the apical plasma membrane enzyme
-GT is
localized dominantly in Clara cells and type II pneumocytes and is a
recognized marker of these cell types (Dinsdale et al., 1992
). In
alveolar macrophages,
-GT activity is 10 times lower than in type II
pneumocytes and has not been detected histochemically (Van Klaveren et
al., 1997
). Accordingly, we did not detect
-GT activity in alveolar macrophages.
Similar to hepatocytes, the culturing of rat type II pneumocytes and
alveolar macrophages results in changes in xenobiotic-metabolizing enzyme activities and intracellular GSH content. Our findings show that
the CYP-related activities do not survive well in type II pneumocytes
and alveolar macrophages in our simple but common culture conditions
since most of the activity was lost at 24 and 3 h, respectively.
The marked reduction in BROD and PROD activities in type II pneumocytes
is consistent with previous studies, showing an approximate 50%
decrease in CYP2B1 apoenzyme expression after 24 h in culture
(Låg et al., 1996
). Similar decreases in BROD and EROD activities were
found in hamster lung slices after 24 h of incubation (Hoet et
al., 1997
). NADPH-cytochrome c reductase activity was more
stable than CYP-related activities.
In general, the phase II-related activities were better kept than those
of phase I enzymes. This is in line with the data obtained on
hepatocytes (Rogiers and Vercruysse, 1993
). In 3-h-attached alveolar
macrophages, there were no changes in GST and DT-diaphorase activity.
In type II pneumocytes, GST activity decreased to a lesser extent
compared with BROD and PROD activities, and at 48 h in culture, it
was 58% of the initial value. In cultured hepatocytes, Niemann et al.
(1991)
described a similar (40%) decrease in GST activity.
The activity of DT-diaphorase in culture has not been extensively
studied. In human fibroblasts, the DT-diaphorase activity increases as
the cells reach confluence and become density growth arrested (Schlager
et al., 1993
). Siegel et al. (1988)
have found a 10% increase in
DT-diaphorase activity 24 h after plating of rat type II
pneumocytes. The observed transient increase in DT-diaphorase activity
in type II pneumocytes at 24 h by 50% and return to the baseline
level at 48 h is difficult to explain.
We observed an increase in intracellular GSH in cultured type II
pneumocytes and alveolar macrophages compared with freshly isolated
cells. These results confirmed our previous observation that there is a
higher GSH content in type II pneumocytes cultured for 24 h rather
than in freshly isolated cells (Dimova et al., 2000
) and are in
agreement with the results of Reynolds et al. (1999)
. The increase GSH
content with time in culture has been shown in primary cultures of
rodent hepatocytes (Ruch et al., 1989
).
In cultured type II pneumocytes, the increase in GSH was associated
with an increase in
-GT activity.
-GT plays an important role in
the regulation of intracellular GSH levels via the
-glutamyl cycle,
and in type II pneumocytes, it has a major role in the use of
extracellular GSH as a source for intracellular GSH (Dinsdale et al.,
1992
).
-GT increases as a part of the adaptation of the cells to
oxidative stress (Kugelman et al., 1994
). Kinnula et al. (1992)
have
found that antioxidant enzyme activities (catalase, glutathione
reductase, and glutathione peroxidase) but not reactive oxygen species
generation by rat type II pneumocytes decrease rapidly in culture. The
increase in
-GT activity and intracellular GSH may represent an
adaptation mechanism of the cells to the changed antioxidant status in
type II pneumocytes in culture.
The balance of metabolic activation and detoxification of xenobiotics
is an important factor for their toxicity and carcinogenesis. The
results of this study have shown that in conventional cultures of type
II pneumocytes and alveolar macrophages, phase II enzyme activities
(GST and quinone oxidoreductase) were better kept than those of phase I
(CYP-related enzymes) and an increase in intracellular GSH occurs.
These shifts in the balance between toxication and detoxication
pathways in cultured rat type II pneumocytes and alveolar macrophages
make the cells in culture more resistant to the toxic action of
xenobiotics than freshly isolated cells. This is apparent with agents
such as acetaminophen in type II pneumocytes (Dimova et al., 2000
).
In conclusion, type II pneumocytes and to a lesser extent alveolar macrophages in primary cultures undergo changes in biotransformation-related enzyme activities and intracellular GSH levels that may affect xenobiotic toxicity at different times in culture. These biochemical changes make the results obtained not necessarily comparable with the in vivo situation and suggest the need for the development of a culture model (mainly for type II pneumocytes) in which the xenobiotic-metabolizing activities are better kept.
| |
Footnotes |
|---|
Received April 4, 2001; accepted July 6, 2001.
This work was supported by a fellowship from the European Respiratory Society to S. Dimova and partly by INCO/Copernicus (EU) (IC15-CT96-0314). This work was partly presented at the 39th Annual Meeting of the Society of Toxicology, Philadelphia, March 19-23, 2000, Abstract in Toxicol Sci (2000) 54 (Suppl):19.
Prof. Benoit Nemery, Laboratory of Pneumology, K. U. Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: ben.nemery{at}med.kuleuven.ac.be
| |
Abbreviations |
|---|
Abbreviations used are:
CYP, cytochrome P450;
GSH, reduced glutathione;
DMEM, Dulbecco's modified Eagle's medium;
FBS, fetal bovine serum;
BROD, 7-benzyloxyresorufin
O-dealkylation;
PROD, 7-pentoxyresorufin
O-dealkylation;
EROD, 7-ethoxyresorufin
O-dealkylation;
GST, glutathione
S-transferase;
-GT,
-glutamyl transferase;
ANOVA, analysis of variance.
| |
References |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||